Veterans / Military

While Cures Within Reach is disease-agnostic and geography-agnostic, some funding partners have strategic interests in specific population groups.  Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Veterans and Military Repurposing Community that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of retired military veterans and active US military.

We launched this on Veterans Day 2020 with our Clinical Repurposing for Veterans Initiative (full press release here).  Our efforts include finding and funding clinical repurposing projects that address unmet and high priority medical needs of veterans and active military, including depression, post-traumatic stress disorder (PTSD) and brain injuries.


Read our news release from April 26, 2022 here, describing the 4 veterans clinical trials selected from our 2021 RFP!

Previous Funding Opportunity RFPs for Veterans / Military:

Clinical Repurposing Research to Impact Veterans: up to $50,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans, including mental health, PTSD and brain injuries. FOUR CLINICAL TRIALS SELECTED FOR FUNDING.


As we develop and grow this Veterans / Military Community, we thank our early funding partner:

Kahlert Foundation

Additional support thanks to:

The Arthur Thomas Alm Trust


Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.

Real World Data Through a Patient’s Lens
October 2021
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.

How Patients Impact the 505(b)(2) Regulatory Process
October 2020
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.

CureAccelerator Live! for Chicago 2020
September 2020
Four finalists from Chicago-based institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials, including one from the VA for brain injury. Watch Dr. Lindsey pitch his brain injury project.

CureAccelerator Live! for the Mid-Atlantic 2018
October 2018
Washington, DC
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials, including one for traumatic nerve injury.  Watch the 3-minute event highlights video.